Keytruda Biosimilar Advances; Oncologist Turned Patient; Will AI Cure Cancer?

(MedPage Today) -- Zydus Lifesciences and Formycon AG announced FDA acceptance of a biologics license application for FYB206, a biosimilar to the blockbuster cancer drug pembrolizumab (Keytruda).
The FDA expanded bladder cancer indications for...